Thermo Fisher Scientific Inc. EO-Notes 2017(17/29)
- BID
96.641
- ASK
96.828
- 500,000 Nom.500,000 Nom.
- 07/27, 19:06:45 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
3.15
Yield spread Bundesanleihe
0.3564
Tradable for private investors
No
Minimum amount tradeable unit
100,000.00
Maturity
24/07/2029
Interest Rate
1.95 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 96.641 G / 3.15 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 07:06:45 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 0.3564 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 96.677 | 96.613 |
| PREV. DAY'S PRICE | 96.585 | (07/24) |
| CHANGE DAY BEFORE | +0.06 | 0.06 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Master Data
| WKN | A19LY9 |
| ISIN | XS1651071950 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Thermo Fisher Scientific Inc. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 1.95 % |
| INTEREST RUN FROM | 24/07/2017 |
| NEXT INTEREST PAYMENT | 10/07/2027 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.102 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 0 |
| MINIMUM AMOUNT TRADEABLE UNIT | 100,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 24/07/2029 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | No |
| BOND IS SUBORDINATED | Yes |
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.